Factors Influencing Health Status and Disability of Patients with Ankylosing Spondylitis in the Czech Republic

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2008 Feb 6

PMID 18247079

Citations 9

Authors

S Forejtova

H Mann

J Stolfa

K Vedral

I Fenclova

D Nemethova

K Pavelka

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age +/- SD of patients was 50.2 +/- 10.7 years, the average symptom duration was 23.0 +/- 11.6 years. Mean time from first symptoms to diagnosis was 9.1 years. Full disability had been awarded to 303 patients (30%) at some point of their disease. Twenty seven percent of patients reported receiving full disability pension for 10 or more years. Four hundred fifty six subjects (45%) were currently or had been previously receiving partial disability pension. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P = 0.012), despite the fact that women had higher BASDAI (P < 0.001) and HAQ-DI (P = 0.004) scores. Patients with a family history of AS had higher BASDAI and HAQ-DI scores (P = 0.001 and P = 0.008, respectively) compared to patients without a family history of AS. BASDAI and HAQ-DI scores correlated with age and duration of illness, younger patients and those with shorter disease duration had lower values. Fifty eight percent of patients reported a BASDAI score > or =4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year. Seven hundred ninety one patients underwent spa treatment in the previous year; 96% of them experienced improvement of their health condition.

Citing Articles

Diagnostic delay in axial spondyloarthritis: a systematic review.

Hay C, Packham J, Ryan S, Mallen C, Chatzixenitidis A, Prior J Clin Rheumatol. 2022; 41(7):1939-1950.

PMID: 35182270 PMC: 9187558. DOI: 10.1007/s10067-022-06100-7.

Angiotensin-Receptor Blockade Improves Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis: ARB-AS Study.

Garg N, Krishan P, Syngle A Int J Angiol. 2021; 30(4):262-270.

PMID: 34853573 PMC: 8608472. DOI: 10.1055/s-0040-1722738.

Gender difference in ASAS HI among patients with ankylosing spondylitis.

Chen H, Chen Y, Lai K, Hsieh T, Hung W, Lin C PLoS One. 2020; 15(7):e0235678.

PMID: 32645080 PMC: 7347111. DOI: 10.1371/journal.pone.0235678.

Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis.

Bubova K, Prajzlerova K, Hulejova H, Gregova M, Mintalova K, Husakova M Physiol Res. 2020; 69(4):653-660.

PMID: 32584134 PMC: 8549897. DOI: 10.33549/physiolres.934414.

Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort.

de Hooge M, Ramonda R, Lorenzin M, Frallonardo P, Punzi L, Ortolan A Arthritis Res Ther. 2016; 18(1):265.

PMID: 27852321 PMC: 5112652. DOI: 10.1186/s13075-016-1162-3.

References

Garrett S, Jenkinson T, Kennedy L, Whitelock H, Gaisford P, Calin A . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21(12):2286-91. View

Lehtinen K . Working ability of 76 patients with ankylosing spondylitis. Scand J Rheumatol. 1981; 10(4):263-5. DOI: 10.3109/03009748109095311. View

Ward M . Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am. 1999; 24(4):815-27, x. DOI: 10.1016/s0889-857x(05)70043-0. View

Calin A, Kennedy L, Edmunds L, Will R . Familial versus sporadic ankylosing spondylitis. Two different diseases?. Arthritis Rheum. 1993; 36(5):676-81. DOI: 10.1002/art.1780360515. View

Ozgul A, Peker F, Taskaynatan M, Tan A, Dincer K, Kalyon T . Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol. 2005; 25(2):168-74. DOI: 10.1007/s10067-005-1150-5. View

Boonen A, van der Heijde D, Landewe R, Guillemin F, Spoorenberg A, Schouten H . Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis. 2003; 62(8):741-7. PMC: 1754633. DOI: 10.1136/ard.62.8.741. View

Taylor A, Balakrishnan C, Calin A . Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum. 1998; 41(6):1119-25. DOI: 10.1002/1529-0131(199806)41:6<1119::AID-ART20>3.0.CO;2-0. View

van Tubergen A, Landewe R, van der Heijde D, Hidding A, Wolter N, Asscher M . Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2001; 45(5):430-8. DOI: 10.1002/1529-0131(200110)45:5<430::aid-art362>3.0.co;2-f. View

Chorus A, Miedema H, Boonen A, van der Linden S . Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis. 2003; 62(12):1178-84. PMC: 1754383. DOI: 10.1136/ard.2002.004861. View

10.

Dagfinrud H, Kjeken I, Mowinckel P, Hagen K, Kvien T . Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol. 2005; 32(3):516-23. View

11.

Ward M, Weisman M, Davis Jr J, Reveille J . Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum. 2005; 53(5):710-7. PMC: 2530902. DOI: 10.1002/art.21444. View

12.

Zink A, Braun J, Listing J, Wollenhaupt J . Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol. 2000; 27(3):613-22. View

13.

Gran J, Skomsvoll J . The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol. 1997; 36(7):766-71. DOI: 10.1093/rheumatology/36.7.766. View

14.

Boonen A, van der Heijde D, Landewe R, Spoorenberg A, Schouten H, Rutten-van Molken M . Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis. 2002; 61(5):429-37. PMC: 1754093. DOI: 10.1136/ard.61.5.429. View

15.

Chorus A, Boonen A, Miedema H, van der Linden S . Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis. 2002; 61(8):693-9. PMC: 1754179. DOI: 10.1136/ard.61.8.693. View

16.

Fautrel B, Guillemin F . Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol. 2002; 14(2):121-6. DOI: 10.1097/00002281-200203000-00008. View

17.

McGuigan L, Hart H, Gow P, Kidd B, Grigor R, Moore T . Employment in ankylosing spondylitis. Ann Rheum Dis. 1984; 43(4):604-6. PMC: 1001418. DOI: 10.1136/ard.43.4.604. View

18.

Boonen A, de Vet H, van der Heijde D, van der Linden S . Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol. 2001; 28(5):1056-62. View

19.

Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W . Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol. 1988; 15(7):1109-14. View

20.

Fries J, Spitz P, Kraines R, HOLMAN H . Measurement of patient outcome in arthritis. Arthritis Rheum. 1980; 23(2):137-45. DOI: 10.1002/art.1780230202. View